Purchase Order 75N91025P00153

<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $12,075.00 firm fixed price purchase order contract to Eurofins Pharma Bioanalytics Services US, LLC, a foreign-owned for-profit organization, for laboratory analysis services. The contract has a period of performance ending on March 19, 2026 and was awarded on March 20, 2025. This contract does not have a set-aside designation.</p>

This is a $45,365 firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract is for the analysis of three compounds in a panel of 50 customized cancer cell lines over a three-month period. The work aims to evaluate the effects of the compounds on cell proliferation, cell death, caspase activity, and...

This is a firm-fixed-price purchase order worth $20,979.04 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract is for binding studies with a period of performance through August 10, 2024. Eurofins Panlabs has received numerous federal contract awards from agencies like NIH, EPA, FDA, and VA to provide...

This is a firm fixed-price delivery order issued by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $359,131 order is for a 1-year period of performance from September 30, 2020 to September 29, 2021 under the NIDA N01DA-18-8937 contract vehicle. The work involves receptor binding and predictive toxicology services to support NIDA's drug...

This is a firm-fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the Department of Health and Human Services, to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract has a total ceiling value of $659,400.00 and a period of performance through September 11, 2024. It was issued under the NIAID's &quot;Nonclinical Services for Development of Interventional Agents&quot;...

This is a $142,193 cost-plus-fixed-fee task order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The task order is for receptor binding and predictive toxicology services to support drug discovery research, with a period of performance from September 26, 2023 to September 25, 2024. Eurofins...

This is a $541,498.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The contract provides nonclinical services in support of the development of interventional agents, and is issued under the Nonclinical Services for Development of Interventional Agents indefinite delivery,...

<p>This is a firm-fixed-price purchase order for laboratory analysis services awarded by the National Cancer Institute, a civilian federal agency, to an unspecified prime contractor. The contract has a ceiling value of $11,075.00 and a period of performance ending on June 30, 2024. No set-aside designation is indicated. The place of performance is Rockville, Maryland.</p>

This is a firm-fixed-price Delivery Order contract awarded to Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $67,783 contract provides lead identification, development, chemistry, and synthesis services to support the NIAID's research and development programs. The contract is part of the NIAID's larger Nonclinical Services for...

The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...